Prosper N Boyaka

11PUBLICATIONS
52CO-AUTHORS
TransgenesisNanomedicineMedical molecular engineering of nucleic acids and proteinsInfant and child healthMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 26, 2025
Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV.

Jiayu Xu, Michelle Chamblee, Fei Jiang

|Aug 06, 2025
Intranasal measles virus- and mumps virus-based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 infection and transmission.

Cheng Chih Hsu, Michelle Chamblee, Chengjin Ye

|Jul 03, 2024
Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective.

Yuexiu Zhang, Michelle Chamblee, Jiayu Xu

|Oct 05, 2023
A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern.

Jiayu Xu, Yuexiu Zhang, Panke Qu

|Aug 22, 2022
SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern.

Mijia Lu, Michelle Chamblee, Yuexiu Zhang

|Jul 27, 2022
A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.

Yuexiu Zhang, Mijia Lu, K C Mahesh

Pageof 2

Frequent Collaborators

6 joint publications

Mahesh Kc

6 joint publications

Mark E Peeples

5 joint publications

Chengjin Ye

4 joint publications

Luis Martinez-Sobrido